Diplomat Pharmacy beats by $0.02, beats on revenue Diplomat Pharmacy (NYSE:DPLO): Q4 EPS of $0.08 beats by $0.02. Revenue of $612M (+48.5% Y/Y) beats by $8.33M. Shares -1.7%.